Interpretable machine learning model for early morbidity risk prediction in patients with sepsis-induced coagulopathy: a multi-center study.

IF 5.9 2区 医学 Q1 IMMUNOLOGY Frontiers in Immunology Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI:10.3389/fimmu.2025.1552265
Ruimin Tan, Chen Ge, Jingmei Wang, Zinan Yang, He Guo, Yating Yan, Quansheng Du
{"title":"Interpretable machine learning model for early morbidity risk prediction in patients with sepsis-induced coagulopathy: a multi-center study.","authors":"Ruimin Tan, Chen Ge, Jingmei Wang, Zinan Yang, He Guo, Yating Yan, Quansheng Du","doi":"10.3389/fimmu.2025.1552265","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sepsis-induced coagulopathy (SIC) is a complex condition characterized by systemic inflammation and coagulopathy. This study aimed to develop and validate a machine learning (ML) model to predict SIC risk in patients with sepsis.</p><p><strong>Methods: </strong>Patients with sepsis admitted to the intensive care unit (ICU) between March 1, 2021, and March 1, 2024, at Hebei General Hospital and Handan Central Hospital (East District) were retrospectively included. Patients were categorized into SIC and non-SIC groups. Data were split into training (70%) and testing (30%) sets. Additionally, for temporal validation, patients with sepsis admitted between March 1, 2024, and October 31, 2024, at Hebei General Hospital were included. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression. Nine ML algorithms were tested, and model performance was assessed using receiver operating characteristic curve (ROC) analysis, including area under the curve (AUC), calibration curves, and decision curve analysis (DCA). The SHaply Additive Explanations (SHAP) algorithm was used to interpret the best-performing model and visualize key predictors.</p><p><strong>Results: </strong>Among 847 patients with sepsis, 480 (56.7%) developed SIC. The random forest (RF) model with eight variables performed best, achieving AUCs of 0.782 [95% confidence interval (CI): 0.745, 0.818] in the training set, 0.750 (95% CI: 0.690, 0.809) in the testing set, and 0.784 (95% CI: 0.711, 0.857) in the validation set. Key predictors included activated partial thromboplastin time, lactate, oxygenation index, and total protein.</p><p><strong>Conclusions: </strong>This ML model reliably predicts SIC risk. SHAP enhances interpretability, supporting early, individualized interventions to improve outcomes in patients with sepsis.</p>","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":"16 ","pages":"1552265"},"PeriodicalIF":5.9000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11911172/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2025.1552265","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sepsis-induced coagulopathy (SIC) is a complex condition characterized by systemic inflammation and coagulopathy. This study aimed to develop and validate a machine learning (ML) model to predict SIC risk in patients with sepsis.

Methods: Patients with sepsis admitted to the intensive care unit (ICU) between March 1, 2021, and March 1, 2024, at Hebei General Hospital and Handan Central Hospital (East District) were retrospectively included. Patients were categorized into SIC and non-SIC groups. Data were split into training (70%) and testing (30%) sets. Additionally, for temporal validation, patients with sepsis admitted between March 1, 2024, and October 31, 2024, at Hebei General Hospital were included. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression. Nine ML algorithms were tested, and model performance was assessed using receiver operating characteristic curve (ROC) analysis, including area under the curve (AUC), calibration curves, and decision curve analysis (DCA). The SHaply Additive Explanations (SHAP) algorithm was used to interpret the best-performing model and visualize key predictors.

Results: Among 847 patients with sepsis, 480 (56.7%) developed SIC. The random forest (RF) model with eight variables performed best, achieving AUCs of 0.782 [95% confidence interval (CI): 0.745, 0.818] in the training set, 0.750 (95% CI: 0.690, 0.809) in the testing set, and 0.784 (95% CI: 0.711, 0.857) in the validation set. Key predictors included activated partial thromboplastin time, lactate, oxygenation index, and total protein.

Conclusions: This ML model reliably predicts SIC risk. SHAP enhances interpretability, supporting early, individualized interventions to improve outcomes in patients with sepsis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于脓毒症诱发凝血病患者早期发病风险预测的可解释机器学习模型:一项多中心研究。
背景:脓毒症诱导的凝血功能障碍(SIC)是一种以全身炎症和凝血功能障碍为特征的复杂疾病。本研究旨在开发和验证机器学习(ML)模型,以预测败血症患者的SIC风险。方法:回顾性分析河北省总医院和邯郸市中心医院(东区)2021年3月1日至2024年3月1日重症监护病房(ICU)收治的脓毒症患者。患者分为SIC组和非SIC组。数据分为训练集(70%)和测试集(30%)。此外,为了进行时间验证,纳入了2024年3月1日至2024年10月31日在河北总医院住院的脓毒症患者。使用最小绝对收缩和选择算子(LASSO)回归和多元逻辑回归进行特征选择。测试了9种ML算法,并使用受试者工作特征曲线(ROC)分析评估模型性能,包括曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)。SHaply加性解释(SHAP)算法用于解释最佳表现模型并可视化关键预测因子。结果:847例败血症患者中,480例(56.7%)发生SIC。具有8个变量的随机森林(RF)模型表现最好,在训练集中的auc为0.782[95%置信区间(CI): 0.745, 0.818],在测试集中的auc为0.750 (95% CI: 0.690, 0.809),在验证集中的auc为0.784 (95% CI: 0.711, 0.857)。关键预测指标包括活化部分凝血活酶时间、乳酸、氧合指数和总蛋白。结论:该ML模型可靠地预测了SIC风险。SHAP提高了可解释性,支持早期个体化干预,以改善败血症患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.80
自引率
11.00%
发文量
7153
审稿时长
14 weeks
期刊介绍: Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
期刊最新文献
Treponema pallidum TprD and TprK are adhesins and their surface expression promotes spirochetal opsonophagocytosis. Establishing an untargeted lipidomics workflow for cellular analysis: insights into endothelial cell function in anaphylaxis. Femoral fracture leads to moderate pulmonary organ damage in aged mice and induces immune alterations. Identification of gemilukast as a bifunctional molecule with lipid-lowering and anti-inflammatory activities. Expanding horizons: radiolabeled FAPI in imaging of autoimmune diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1